HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Osiris Therapeutics Inc.

Division of Smith & Nephew PLC
http://www.osiris.com

Latest From Osiris Therapeutics Inc.

Market Brief: Orthobiologics Market Will See Modest Growth By 2024, Stimulated By Growth Factors

Global sales of orthobiologics products are expected to reach $2.8bn by 2024, a CAGR of 3.2%, led by the rising aging population and musculoskeletal disease.

Orthopedics Innovation

MTI Top 100: Leading Medtechs See Steady Organic Growth In A Market On The Cusp Of Change

The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings. 

International Commercial

Deal Time! Smith & Nephew Snaps Up Leaf Healthcare For Wound Portfolio

Smith & Nephew is continuing its acquisition spree by picking up Leaf Healthcare, the developer of a pressure injury prevention device, to bolster its advanced wound management portfolio.

M & A Commercial

Mesoblast’s Late-Stage Pipeline Could Be Game Changing: Are Investors Paying Attention?

Mesenchymal cell specialist Mesoblast came back from a near-death experience in 2016 when Teva returned a key asset. But recent success in a Phase III trial in acute GVHD has brought it some attention. Now it needs to repeat the achievement in advanced heart failure and find a partner for its burgeoning pipeline.

Regenerative Medicine Research & Development
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Smith & Nephew PLC
  • Senior Management
  • Samson Tom, Pres. & CEO
    Joel Rogers, CFO
    Alla Danilkovitch, PhD, CSO
    Jason Keefer, Chief Commercial Officer
  • Contact Info
  • Osiris Therapeutics Inc.
    Phone: (443) 545-1819
    7015 Albert Einstein Dr.
    Columbia, MD 21046-1707
    USA
UsernamePublicRestriction

Register